Neutraflush
NDC 55305-134, Eyewash Station Additive Concentrate, liquid, from Aero Healthcare.
- Product NDC
- 55305-134
- Status
- Listed
- Labeler
- Aero Healthcare
- Dosage form
- LIQUID
- Route
- OPHTHALMIC
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M018
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/55305-134 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PROPYLENE GLYCOL280 kg/2800L
- CHLORHEXIDINE GLUCONATE145.6 kg/2800L
Pharmacologic classes
Decreased Cell Wall Integrity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 55305-134-01 | 55305013401 | .236 L in 1 BOTTLE (55305-134-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 55305-134 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/55305-134 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 55305-134. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.